Hong Kong Trade Distributors Stock News

Sands China (SEHK:1928) is back in focus after being confirmed as the Official Promoter for the NBA China Games 2026 at The Venetian Arena in Macao, featuring the Dallas Mavericks and Houston Rockets. See our latest analysis for Sands China. Alongside the NBA China Games announcement and the renewal of its shared services agreement with Las Vegas Sands Corp. through 2028, Sands China’s recent share price performance has been mixed. A 1-day share price return of 0.96% contrasts with a 30-day...

Grand Pharmaceutical Group has announced that Neffy®, the world’s first adrenaline nasal spray, has obtained drug registration approval from China’s National Medical Products Administration for emergency treatment of type I allergic reactions in adults and children over 30kg, with exclusive commercialization rights in Mainland China and planned localized production within 24 months. This marks the first non-injectable adrenaline treatment approved in China, potentially broadening real-world...

Key Insights Significant control over JD Health International by public companies implies that the general public has...

Poly Property Services (HKG:6049) has had a rough month with its share price down 4.1%. However, stock prices are...

Key Insights Sunny Optical Technology (Group)'s estimated fair value is HK$95.31 based on 2 Stage Free Cash Flow to...

What Prada’s recent share performance tells you Prada (SEHK:1913) has drawn attention after a period of weaker share performance, with the stock down over the past month, past 3 months and year. This has prompted investors to reassess expectations around its current valuation. See our latest analysis for Prada. At a share price of HK$43.30, Prada’s weaker recent share price returns, including a 90 day share price return decline of 7.32%, sit alongside a 1 year total shareholder return decline...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...

BYD Company Limited recently reported unaudited 2025 figures showing full-year production of 4,537,356 vehicles and sales of 4,602,436 vehicles, alongside weaker December volumes compared with a year earlier. These results confirm BYD sold around 2.3 million all-electric cars in 2025, surpassing Tesla and becoming the world’s largest pure EV seller. Next, we’ll assess how BYD’s emergence as the top all-electric vehicle seller globally influences the company’s broader investment...

As global markets navigate a complex landscape, Asian stocks remain a focal point for investors seeking opportunities beyond traditional boundaries. Penny stocks, despite their somewhat outdated moniker, continue to capture interest due to their potential for growth and affordability. This article explores three Asian penny stocks that exhibit financial strength and the potential for long-term value.

As global markets navigate a complex landscape marked by mixed performances in major indices and evolving economic conditions, Asia presents intriguing opportunities for investors seeking to uncover potential growth stories. In this dynamic environment, identifying stocks with robust fundamentals becomes crucial, as strong financial health and strategic positioning can help companies weather market fluctuations and capitalize on emerging trends.

Key Insights The projected fair value for China Nonferrous Mining is HK$26.03 based on 2 Stage Free Cash Flow to Equity...

Key Insights Haitian International Holdings' estimated fair value is HK$43.30 based on 2 Stage Free Cash Flow to Equity...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...

Onewo Inc. ( HKG:2602 ), is not the largest company out there, but it received a lot of attention from a substantial...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Key Insights Using the 2 Stage Free Cash Flow to Equity, InnoCare Pharma fair value estimate is HK$23.47 Current share...

Key Insights The considerable ownership by individual investors in Shanghai Bio-heart Biological Technology indicates...

It's not a stretch to say that Snack Empire Holdings Limited's ( HKG:1843 ) price-to-sales (or "P/S") ratio of 0.5x...

Qyuns Therapeutics Co., Ltd. ( HKG:2509 ) is possibly approaching a major achievement in its business, so we would like...

Viewing insider transactions for Wai Hung Group Holdings Limited's ( HKG:3321 ) over the last year, we see that...

There wouldn't be many who think China Feihe Limited's ( HKG:6186 ) price-to-earnings (or "P/E") ratio of 11.8x is...

It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...

Shanghai Chicmax Cosmetic (HKG:2145) has had a rough three months with its share price down 26%. However, a closer look...

Q Technology (Group) Company Limited ( HKG:1478 ) shareholders might understandably be very concerned that the share...